|
▽
|
VBTX |
Veritex Holdings, Inc. |
Financial Services |
11.6 |
3.6 |
13.2 |
0 |
40.3 |
15.1 |
1.1 |
2.0 |
7.1 |
-11.01 |
24.1 |
|
|
12.36 |
2, 5, 8, 11 |
2024-11-25 |
| Veritex Holdings, Inc. operates as the bank holding company for Veritex Community Bank. It provides various commercial banking products and services to small and medium-sized businesses, and professionals. The company accepts deposit products include demand, |
|
▽
|
VC |
Visteon Corporation |
Consumer Cyclical |
13.2 |
0.0 |
|
0 |
0.0 |
5.2 |
2.4 |
17.6 |
46.8 |
-13.10 |
12.3 |
1.74 |
1.42 |
38.06 |
1 |
2024-11-25 |
| Visteon Corporation designs, manufactures, and sells automotive electronics and connected car solutions for vehicle manufacturers worldwide. It offers instrument clusters, including analog gauge clusters for 2-D and 3-D display-based devices. The company also provides |
|
▽
|
VCEL |
Vericel Corporation |
Healthcare |
6.7 |
|
|
None |
|
-916.9 |
12.9 |
-0.1 |
-1.4 |
-14.08 |
-1.6 |
4.49 |
4.21 |
63.89 |
|
2024-11-25 |
| Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets MACI, |
|
▽
|
VCTR |
Victory Capital Holdings, Inc. |
Financial Services |
35.4 |
3.8 |
94.3 |
4 |
39.1 |
20.9 |
4.2 |
3.3 |
20.2 |
-1.55 |
26.0 |
0.79 |
|
41.41 |
3, 6, 9, 12 |
2024-11-25 |
| Victory Capital Holdings, Inc. operates as an asset management company in the United States and internationally. It offers investment advisory, fund administration, fund compliance, fund transfer agent, fund distribution, and other management services. The company's investment |
|
▽
|
VCYT |
Veracyte, Inc. |
Healthcare |
20.1 |
|
|
None |
|
-41.2 |
2.9 |
-1.0 |
-7.1 |
-30.11 |
-20.6 |
4.66 |
4.40 |
93.65 |
|
2024-11-25 |
| Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Pro |
|
▽
|
VECO |
Veeco Instruments Inc. |
Technology |
22.8 |
|
|
None |
|
-51.2 |
2.3 |
-0.5 |
-4.5 |
-11.64 |
-4.6 |
3.24 |
2.15 |
54.71 |
|
2024-11-25 |
| Veeco Instruments Inc. develops, manufactures, sells, and supports semiconductor and thin film process equipment. The company offers laser annealing, ion beam deposition and etch, metal organic chemical vapor deposition, single wafer wet processing |
|
▽
|
VEEV |
Veeva Systems Inc. |
Healthcare |
25.7 |
|
|
None |
|
66.7 |
7.6 |
3.2 |
11.3 |
-14.60 |
22.2 |
4.24 |
|
78.58 |
|
2024-11-25 |
| Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions. The company also provides applications for the clinical, regulatory, quality, |
|
▽
|
VEL |
Velocity Financial, Inc. |
Financial Services |
58.6 |
|
|
None |
|
12.9 |
1.6 |
1.6 |
12.1 |
-23.73 |
33.6 |
|
|
9.84 |
|
2024-11-25 |
| Velocity Financial, Inc. operates as a real estate finance company in the United States. It originates, securitizes, and manages a portfolio of loans, which are secured by first mortgage liens on income-producing and/ |
|
▽
|
VERA |
Vera Therapeutics, Inc. |
Healthcare |
-23.5 |
|
|
None |
|
-31.9 |
30.1 |
-1.5 |
-94.4 |
|
|
7.71 |
|
57.92 |
|
2024-11-25 |
| Vera Therapeutics, Inc. focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection. |
|
▽
|
VERV |
Verve Therapeutics, Inc. |
Healthcare |
-38.5 |
|
|
None |
|
-2.1 |
0.7 |
-2.4 |
-33.4 |
-91.75 |
|
17.24 |
|
79.65 |
|
2024-11-25 |
| Verve Therapeutics, Inc. engages in developing gene editing medicines for patients to treat cardiovascular diseases in the United States. The company's lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns |